150 related articles for article (PubMed ID: 37145713)
1. Impact of Zone of Origin in Anterior Dominant Prostate Cancer: Long-Term Biochemical Recurrence-Free Survival in an Anatomically Well-Characterized Cohort.
Fine SW; Al-Ahmadie HA; Vertosick E; Vickers AJ; Chen YB; Gopalan A; Sarungbam J; Sirintrapun SJ; Tickoo SK; Eastham JA; Scardino PT; Reuter VE
Urol Pract; 2022 Sep; 9(5):459-465. PubMed ID: 37145713
[TBL] [Abstract][Full Text] [Related]
2. Prostate carcinoma with positive margins at radical prostatectomy: role of tumour zonal origin in biochemical recurrence.
O'Neil LM; Walsh S; Cohen RJ; Lee S
BJU Int; 2015 Oct; 116 Suppl 3():42-8. PubMed ID: 26218868
[TBL] [Abstract][Full Text] [Related]
3. The prognostic value of zonal origin and extraprostatic extension of prostate cancer for biochemical recurrence after radical prostatectomy.
Takamatsu K; Matsumoto K; Shojo K; Tanaka N; Takeda T; Morita S; Kosaka T; Mizuno R; Shinojima T; Kikuchi E; Asanuma H; Oya M
Urol Oncol; 2019 Sep; 37(9):575.e19-575.e25. PubMed ID: 30967332
[TBL] [Abstract][Full Text] [Related]
4. Anterior-predominant prostatic tumors: zone of origin and pathologic outcomes at radical prostatectomy.
Al-Ahmadie HA; Tickoo SK; Olgac S; Gopalan A; Scardino PT; Reuter VE; Fine SW
Am J Surg Pathol; 2008 Feb; 32(2):229-35. PubMed ID: 18223325
[TBL] [Abstract][Full Text] [Related]
5. Zonal origin of localized prostate cancer does not affect the rate of biochemical recurrence after radical prostatectomy.
Chun FK; Briganti A; Jeldres C; Erbersdobler A; Schlomm T; Steuber T; Gallina A; Walz J; Perrotte P; Huland H; Graefen M; Karakiewicz PI
Eur Urol; 2007 Apr; 51(4):949-55; discussion 955. PubMed ID: 16904818
[TBL] [Abstract][Full Text] [Related]
6. Do prostatic transition zone tumors have a distinct morphology?
Garcia JJ; Al-Ahmadie HA; Gopalan A; Tickoo SK; Scardino PT; Reuter VE; Fine SW
Am J Surg Pathol; 2008 Nov; 32(11):1709-14. PubMed ID: 18769336
[TBL] [Abstract][Full Text] [Related]
7. Analysis of differences in clinicopathological features between prostate cancers located in the transition and peripheral zones.
Sakai I; Harada K; Kurahashi T; Yamanaka K; Hara I; Miyake H
Int J Urol; 2006 Apr; 13(4):368-72. PubMed ID: 16734852
[TBL] [Abstract][Full Text] [Related]
8. Transition zone prostate cancer is associated with better clinical outcomes than peripheral zone cancer.
Sato S; Kimura T; Onuma H; Egawa S; Takahashi H
BJUI Compass; 2021 May; 2(3):169-177. PubMed ID: 35475132
[TBL] [Abstract][Full Text] [Related]
9. A comparison of the biological features between prostate cancers arising in the transition and peripheral zones.
Sakai I; Harada K; Hara I; Eto H; Miyake H
BJU Int; 2005 Sep; 96(4):528-32. PubMed ID: 16104904
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathologic Significance of Anterior Prostate Cancer: Comparison With Posterior Prostate Cancer in the Era of Multiparametric Magnetic Resonance Imaging.
Samaratunga H; Egevad L; Yaxley JW; Johannsen S; Le Fevre IK; Perry-Keene JL; Gianduzzo T; Chabert C; Coughlin G; Parkinson R; Kua B; Yaxley W; Delahunt B
Am J Surg Pathol; 2023 Jun; 47(6):701-708. PubMed ID: 37057830
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of prostate cancer originating from the transition zone.
King CR; Ferrari M; Brooks JD
Urol Oncol; 2009; 27(6):592-7. PubMed ID: 18799332
[TBL] [Abstract][Full Text] [Related]
12. Postoperative Biochemical Failure in Patients With PI-RADS Category 4 or 5 Prostate Cancers: Risk Stratification According to Zonal Location of an Index Lesion.
Shin N; Park SY
AJR Am J Roentgenol; 2020 Oct; 215(4):913-919. PubMed ID: 32755167
[No Abstract] [Full Text] [Related]
13. Relationship between clinical stage and histological zone of origin in early prostate cancer: morphometric analysis.
Greene DR; Wheeler TM; Egawa S; Weaver RP; Scardino PT
Br J Urol; 1991 Nov; 68(5):499-509. PubMed ID: 1747726
[TBL] [Abstract][Full Text] [Related]
14. Zonal origin of prostate cancer: comparison of long-term outcomes after radical prostatectomy.
Luttrell L; Li J; Cohen RJ
Int Urol Nephrol; 2023 Aug; 55(8):1951-1956. PubMed ID: 37256425
[TBL] [Abstract][Full Text] [Related]
15. Biochemical recurrence following radical prostatectomy: a comparison between prostate cancers located in different anatomical zones.
Augustin H; Erbersdobler A; Graefen M; Fernandez S; Palisaar J; Huland H; Hammerer P
Prostate; 2003 Apr; 55(1):48-54. PubMed ID: 12640660
[TBL] [Abstract][Full Text] [Related]
16. TMPRSS2-ERG rearrangement in dominant anterior prostatic tumours: incidence and correlation with ERG immunohistochemistry.
Gopalan A; Leversha MA; Dudas ME; Maschino AC; Chang J; Al-Ahmadie HA; Chen YB; Tickoo SK; Reuter VE; Fine SW
Histopathology; 2013 Aug; 63(2):279-86. PubMed ID: 23701505
[TBL] [Abstract][Full Text] [Related]
17. [Clinicopathological study of prostate cancer patients who had a serum PSA level of more than 20 ng/ml and were treated by a radical prostatectomy].
Udo K; Otsubo S; Sakamoto N; Iguchi A
Nihon Hinyokika Gakkai Zasshi; 2007 Jul; 98(5):685-90. PubMed ID: 17682447
[TBL] [Abstract][Full Text] [Related]
18. Transition zone biopsy and prediction of extraprostatic extension at radical prostatectomy.
Onder AU; Yaycioglu O; Ataus S; Gul U; Demirkesen O; Yalcin V; Solok V
Int J Urol; 2003 Jun; 10(6):302-6; discussion 307-8. PubMed ID: 12757598
[TBL] [Abstract][Full Text] [Related]
19. Patterns of spread of adenocarcinoma in the prostate as related to cancer volume.
McNeal JE; Haillot O
Prostate; 2001 Sep; 49(1):48-57. PubMed ID: 11550210
[TBL] [Abstract][Full Text] [Related]
20. Cellular density of low-grade transition zone prostate cancer: A limiting factor to correlate restricted diffusion with tumor aggressiveness.
Barral M; Jemal-Turki A; Beuvon F; Soyer P; Camparo P; Cornud F
Eur J Radiol; 2020 Oct; 131():109230. PubMed ID: 32866908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
